| CAS: | 596-51-0 | |||||||||||||||
| 分子式: | C19H28BrNO3 | |||||||||||||||
| 分子量: | 398.34 | |||||||||||||||
| 熔点: | 193 - 194.5°C | |||||||||||||||
| 中文名称: |
| |||||||||||||||
| 英文名称: |
| |||||||||||||||
| 性质描述: | 该品为白色结晶性粉末,无臭,味苦。在水、甲醇或乙醇中易溶,在氯仿或乙醚中几乎不溶。熔点:191-195℃。 | |||||||||||||||
| 用途: | 抗胆碱药。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| G855651 | MACKLIN | 甘洛溴铵 | 97% | 774元/1g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
储存: 2-8°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| G0392 | TCI | Glycopyrrolate | >98.0%(T)(HPLC) | 1350元/100MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 358978 | J&K | Glycopyrrolate | 98%, 一种竞争性毒蕈碱拮抗剂, 可解痉挛 | 476元/25MG; 1568元/100MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Glycopyrrolate是毒蕈碱拮抗剂。在胃肠道疾病中,被用作止痉挛药。 靶点(IC50 & Targe) mAChR M1 体外研究 Glycopyrrolate以剂量依赖方式抑制由EFS诱导的豚鼠气管和人类呼吸道的收缩。在竞争性研究中,glycopyrrolate结合人类肺外围和呼吸道平滑肌(HASM)毒蕈碱型受体,其亲和力单位在纳摩尔级别(Ki=0.5-3.6 nM)。Glycopyrrolate对M1-M3受体的结合没有选择性。动力学研究表明,glycopyrrolate缓慢地从HASM毒蕈碱型受体解离出来[1]。 参考文献 [1] Haddad EB, et al. Br J Pharmacol. 1999, 127(2):413-20. [2] Schroeder AM, et al. PLoS Curr. 3:RRN1266. 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| C46632 | Alfa Aesar | Glycopyrronium bromide | 5897元/250mg; 19450元/1g; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息 Ref# 分子式 分子量 GHS危害和防范说明 GHS符号 Hazard Statements Precautionary Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0001358 | Glycopyrronium impurity N | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Glycopyrrolate is long-acting muscarinic antagonist (LAMA). It is kinetically selective muscarinic M3 receptor antagonist. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0001308 | Glycopyrronium bromide | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Glycopyrrolate is long-acting muscarinic antagonist (LAMA). It is kinetically selective muscarinic M3 receptor antagonist. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0001309 | Glycopyrronium for peak identification | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Glycopyrrolate is long-acting muscarinic antagonist (LAMA). It is kinetically selective muscarinic M3 receptor antagonist. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SML0029 | Sigma-Aldrich | Glycopyrrolate | ≥98% (HPLC) | 957.62元/5 MG; 3862.87元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Glycopyrrolate is a quaternary ammonium compound and it shows structural similarity with atropine. 包装 5, 25 mg in glass bottle 生化/生理作用 Glycopyrrolate is an anti-cholinergic drug. It is a potent controller of drooling, observed in children affected with cerebral palsy. Compared to other muscarinic antagonists, glycopyrrolate has lower CNS (central nervous system) penetration. 特点和优势 This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1296009 | USP | Glycopyrrolate | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 生化/生理作用 Glycopyrrolate is long-acting muscarinic antagonist (LAMA). It is kinetically selective muscarinic M3 receptor antagonist. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BP1110 | Glycopyrronium bromide | British Pharmacopoeia (BP) Reference Standard | 2244.51元/100 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Glycopyrrolate is long-acting muscarinic antagonist (LAMA). It is kinetically selective muscarinic M3 receptor antagonist. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 471601 | Fluorochem | Glycopyrrolate | 95% | 6204元/100mg; 21670元/500mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||